Watch Dr. Afshin Safavi, BioAgilytix Global CSO discuss why it is important to look at ROI when deciding on what new bioanalytical technologies to invest in – both from a financial perspective, and in the effort it will take to move a drug forward as part of the “Business of Bioanalysis” panel hosted by Bioanalysis Zone.
*Video Produced by Bioanalysis Zone
Learn how BioAgilytix provides the
See how our PK expertise complements our immunogenicity services by evaluating
Learn why we’re a trusted partner to
What are your specific assay needs? Let’s schedule a conversation to review your
questions and requirements with one of our scientists.
Learn how BioAgilytix provides the
See how our PK expertise complements our immunogenicity services by evaluating
Learn why we’re a trusted partner to
What are your specific assay needs? Let’s schedule a conversation to review your
questions and requirements with one of our scientists.
Platforms
Services